DOI: https://doi.org/10.21203/rs.3.rs-392648/v1
Aim: To evaluate the risk factors, clinical presentation, management and outcome of inadvertent globe perforation during peribulbar anaesthesia.
Methods: This retrospective study evaluated the medical records of all the patients treated for globe perforation secondary to peribulbar block preceding ocular surgery from 2012 to 2020. The patients were divided into three groups; Group 1 - clear media with no retinal detachment (RD); group 2 - vitreous hemorrhage (VH) without RD; and group 3 - RD with/without VH.
Results: Twenty-five patients (25 eyes) were identified. The incidence of globe perforation was 0.002 %. The mean axial length (AL) was 24.7±2.7mm (Range, 20.9-31.2mm). Eleven eyes (45.8%) had AL≥24mm.
The most common presenting features were VH (n=14), ocular hypotony (n=7) and RD (n=7). The treatment included laser photocoagulation for the retinal break(s) (n=7) and vitrectomy (n=17). Retinal breaks were identified in all the patients (total breaks, 37). Other complications included full-thickness macular hole (n=5), subretinal haemorrhage (n=4) and retinal vascular occlusions (n=4).
Mean presenting best-corrected visual acuity (BCVA) in group 1,2 and 3 were logMAR 0.79±0.73, 1.82±0.78 and 2.13±0.59 respectively. All the patients, except one who did not undergo surgery due to advanced proliferative vitreoretinopathy, had an attached retina at the time of last follow-up. The mean final BCVA was logMAR 0.59±0.79, 0.48±0.26 and 1.25±0.64 respectively.
Conclusion: Early intervention can help manage the eyes with inadvertent perforation successfully. The presence of retinal detachment, as well as macular and vascular complications are risk factors for poor prognosis.
The akinesia required for ocular surgeries is usually achieved using local anaesthesia. The various methods of achieving this anaesthesia include retrobulbar, peribulbar and subtenon injections. All these methods are quick and highly effective in achieving their aims. However, unfortunately all these procedures are blind and can lead to inadvertent globe perforations.1–31
An incidence of 0.006–0.13% for globe perforation after retrobulbar and peribulbar anaesthesia has been reported.1,2,9,12,21 This can lead to complications like retinal breaks, subretinal haemorrhage (SRH) around retinal breaks, vitreous haemorrhage (VH), retinal detachment (RD) or endophthalmitis.1–31 Inadvertent intraocular injection of the anesthetic agent can be even more dangerous.11,17
This study was done to evaluate the risk factors, clinical presentation, management and outcome of inadvertent globe perforations during peribulbar anaesthesia at a tertiary care ophthalmic institute.
This was a retrospective study conducted at a tertiary-care eye hospital in South India. The study was conducted with the approval of the Institutional Review Board (Registration No. ECR/182/INST/TN/2013, dated 20.04.2013) and adhered to the tenets of the Declaration of Helsinki. Informed consent was taken from the patients after explaining the nature of surgery and its associated complications.
The medical records of all the patients who were treated for globe perforation secondary to peribulbar block preceding ocular surgery from 2012 to 2020 were reviewed. The patients included both the in-house complications as well those referred from outside. The data reviewed included demographics of the patients; axial length; presenting best-corrected visual acuity (BCVA), intraocular pressure and complete dilated examination; interval between the needle perforation and development of secondary complications; management; final anatomical and visual outcome; and the cause(s) of poor outcome. B-scan ultrasound was done whenever appropriate. All patients were treated by one surgeon (NB).
During the first five years of the study, i.e. from 2012 to 2017, only peribulbar blocks were used. A percutaneous injection of a mixture of bupivacaine, lidocaine, and hyaluronidase was injected using a sharp 25-gauge disposable needle with the patient in supine position and both eyes open. First injection was given at the junction of the medial two-thirds and the lateral third of the lower orbital margin using index finger of the spare hand to push the globe superiorly. In case of inadequate akinesia, a second injection was given at the junction of the medial one-third and lateral two-thirds of the superior orbital margin with index finger of the spare hand to push the globe inferiorly.
During the next three years of the study, i.e. from 2018 to 2020, subtenon blocks were used. Topical anaesthetic drops were used to anesthetise the conjunctiva followed by Povidone-iodine (5.0%) topical drops to sterlise the conjunctival sac. A small cut was made in the fused conjunctiva and anterior Tenon’s capsule in the infero-nasal quadrant, 7–10 mm from the limbus, to access the sub-Tenon’s space. Blunt dissection was then done using Westcott scissors to space a thin channel in the posterior sub-Tenon’s space till the globe equator. A mixture of bupivacaine and lidocaine was injected using a blunt disposable cannula with the patient in supine position and both eyes open.
The patients presenting with significant vitreous hemorrhage precluding retinal view, with or without retinal detachment (RD), were taken up for 23-gauge pars plana vitrectomy (PPV) within one week of presentation. Posterior vitreous detachment (PVD) induction with the help of intravitreal triamcinolone acetonide and internal limiting membrane (ILM) peeling was done in all the cases. The type of tamponade, 20% sulphur hexafluoride (SF6) or 1000 centistokes silicon oil (SO), was decided depending upon the intra-operative findings. The patients presenting with no or minimal VH and visible retinal breaks were immediately treated with either laser photocoagulation or cryotherapy.
The patients were divided into three groups. Group 1 included the patients who presented with a clear media with no RD; group 2 included the patients who presented with VH without RD; while group 3 included the patients who presented with RD with or without VH. The patients lost to follow-up were excluded from the study (Fig. 1).
Statistical analysis was performed with STATA statistical software, Version 11.1 (StataCorp, College Station, Texas, USA). Continuous variables were expressed as mean (± standard deviation) and categorical variables were expressed as percentages. Comparison between categorical data was performed with Chi-square/ Fisher exact test while difference in continuous data was measured with Student t-test/ Mann-Whitney test. One-way analysis of variance was applied to compare continuous variables in each group over time. Regression analysis was performed to find the effect of patient variables on the change in pressure measurements during the procedure. A two-tailed P value less than 0.05 was considered to be statistically significant.
Using the electronic medical record, we could find 26 patients with globe perforations. However, one patient who was referred from outside refused treatment. Twenty-five patients (25 eyes) received treatment, out of which 13 mere males and 12 were females. The mean age was 59.2 ± 11.0 years (Range, 36–72 years). While 10 patients were referred from outside, 15 were in-house complications (Fig. 1). The incidence of in-house globe perforation was 0.002% (n = 15/595052). There have been no such inadvertent incidents after shifting to subtenon anaesthesia.
The ocular surgery which the patients were about to undergo included cataract surgery (n = 23), silicon oil removal (SOR) with drainage implant (n = 1) and penetrating keratoplasty (PKP, n = 1). The mean axial length (AL) was 24.7 ± 2.7mm (Range, 20.9-31.2mm). Eleven eyes (45.8%) had AL ≥ 24mm and six (24.0%) had AL ≥ 26mm.
The inadvertent scleral perforation was recognised intra-operatively in 9 eyes (36.0%), out of which the planned surgery was postponed in 2 patients and continued in the rest. An inadvertent perforation was suspected on post-operative day 1 (POD-1), POD-30 and POD-120 in 14 (56.0%), 1 (4.0%) and 1 (4.0%) patient respectively. No intra-operative complications were noted in any of the patients with inadvertent perforation. Among the fifteen in-house perforations, the scleral perforation was recognised/ suspected intra-operatively and on POD-1 in eight and six patients respectively. One patient who underwent PKP was suspected to have scleral perforation only after one month. The patient presenting after 4 months was referred form outside.
The most common presenting features were VH (n = 14, 56.0%), ocular hypotony (n = 7, 28.0%), RD (n = 7, 28.0%) and hyphaema (n = 2, 8.0%). The treatment included laser photocoagulation or cryotherapy for the retinal break(s) (n = 7, 28.0%) and PPV (n = 17, 68.0%). One patient who was referred from outside after the suspected perforation, which was recognised immediately and cataract surgery was aborted, presented to our hospital after 3 months. He had a dense cataract and total RD on B-scan. While he underwent cataract surgery, vitrectomy was avoided in view of advanced proliferative vitreoretinopathy (PVR) changes and poor visual prognosis.
The patients undergoing vitrectomy were operated within the first week except for two patients. The reason for delayed surgery was late referral from outside in one patient and late diagnosis in the other in-house patient due to PKP. Retinal breaks were identified in all the patients. A total of 37 breaks were recognised with 3 breaks noted in two patients and 2 breaks in eight patients (Fig. 2–4). Other complications recognised as the media cleared after vitrectomy included full-thickness macular hole (FTMH, n = 5,20%), subretinal haemorrhage (SRH, n = 4, 16.0%), retinal necrosis (n = 3, 12%), central retinal artery occlusion (CRAO, n = 2, 8.0%), branch retinal artery occlusion (BRAO, n = 1, 4.0%) and central retinal vein occlusion (CRVO, n = 1, 4.0%). No case of endophthalmitis was noted.
Group 1 included eight patients (32.0%). The mean presenting BCVA was logMAR 0.79 ± 0.73 (Snellen equivalent, 20/123). One patient who had undergone vitrectomy for RRD and was planned for SOR had an inadvertent perforation. He underwent an uncomplicated surgery along with endolaser to the perforation site. Other patients underwent laser photocoagulation. The mean final BCVA was logMAR 0.59 ± 0.79 (Snellen equivalent, 20/78). One patient presented with CRAO and had finger counting vision (Table 1).
S. No | Age/ Sex | Initial BCVA | AL | Complications | Management | Anatomical outcome | Final BCVA |
---|---|---|---|---|---|---|---|
13 | 65/M | 20/20 | 24.15 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/20 |
16 | 47/F | 20/60 | 23.56 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/60 |
17 | 65/F | 20/200 | 23.09 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/80 |
19 | 49/M | 20/300 | 23.89 | Retinal break, hypotony | Laser photocoagulation* | Attached retina | 20/80 |
20 | 60/M | 20/120 | 23.84 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/40 |
21 | 58/F | 20/40 | 23.24 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/20 |
24 | 70/M | FC | 22.93 | Retinal break, CRAO | Laser photocoagulation | Attached retina | FC |
25 | 47/F | 20/60 | 23.47 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/60 |
(BCVA: Best-corrected visual acuity; AL: Axial length; *: Planned for silicon oil removal with drainage implant - underwent additional endolaser; FC: Finger counting; CRAO: Central retinal artery occlusion) |
Group 2 included ten patients (40.0%). The mean presenting BCVA was logMAR 1.82 ± 0.78 (Snellen equivalent, 20/1321). All patients underwent vitrectomy with SO tamponade in eight patients and SF6 gas tamponade in two patients. The other associated complications in this group included FTMH (n = 2), SRH (n = 2), CRVO (n = 1) and macular pucker with break around the supero-temporal arcade (n = 1). All patients underwent SOR and had an attached retina till the last follow-up. The mean final BCVA was logMAR 0.61 ± 0.20 (Snellen equivalent, 20/81) (Table 2).
S. No | Age/ Sex | Initial BCVA | AL | Complications | Management | Anatomical outcome | Final BCVA |
---|---|---|---|---|---|---|---|
1 | 65/M | HM | 23.8 | Retinal break | Vitrectomy, endolaser, SO | Attached retina | 20/60 |
2 | 80/M | PL+ | 24.06 | Retinal break, SRH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
4 | 60/M | 20/400 | 21.5 | Retinal break, SRH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
6 | 55/M | 20/200 | 29.37 | Retinal break | Vitrectomy, endolaser, SO | Attached retina | 20/40 |
7 | 60/F | FC | 29.04 | Retinal break, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
8 | 65/F | 20/1200 | 23.68 | Retinal break, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
9 | 55/M | PL+ | 21.54 | Retinal break, CRVO | Vitrectomy, endolaser, SO | Attached retina | 20/80 |
14 | 50/M | 20/1200 | 20.9 | Retinal break, macular pucker | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
15 | 75/M | 20/2400 | 22.96 | Retinal break | Vitrectomy, endolaser, SF6 | Attached retina | 20/40 |
23 | 71/F | 20/800 | 22.77 | Retinal break | Vitrectomy, endolaser, SF6 | Attached retina | 20/60 |
(BCVA: Best-corrected visual acuity; AL: Axial length; HM, Hand movement; SO: Silicon oil; PL: Perception of light; SRH: Subretinal haemorrhage; FC: Finger counting; FTMH: Full-thickness macular hole; CRVO: Central retinal vein occlusion SF6: Sulphur hexafluoride) |
Group 3 included seven patients (28.0%). The mean presenting BCVA was logMAR 2.13 ± 0.59 (Snellen equivalent, 20/2698). All the patients underwent vitrectomy with SO tamponade except for one patient who presented with advanced PVR changes and poor visual prognosis. The other complications included VH (n = 5), SRH (n = 2), BRAO (n = 1) and CRAO (n = 1). All patients underwent SOR and had an attached retina till the last follow-up. The mean final BCVA was logMAR 1.25 ± 0.64 (Snellen equivalent, 20/356). Two patients had a final BCVA ≤ 20/1200 due to CRAO and failed PKP graft respectively (Table 3).
S. No | Age/ Sex | Initial BCVA | AL | Complications | Management | Anatomical outcome | Final BCVA |
---|---|---|---|---|---|---|---|
3 | 60/F | HM | 25.77 | VH, Retinal break, SRH, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/1200 |
5 | 55/F | PL+ | 26.89 | VH, Retinal break, SRH, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
10 | 72/F | 20/400 | 24.3 | VH, Retinal break, IT-BRAO | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
11 | 42/M | 20/200 | 31.22 | VH, Retinal break, hypotony | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
12 | 46/M | FC | 29.59 | VH, Retinal break, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/240 |
18 | 36/F | 20/1200 | 24.18 | Retinal break | Vitrectomy, endolaser, SO | Attached retina | FC |
22 | 71/F | PL+ | 26.89 | Retinal break | nil* | RD | PL+ |
(BCVA: Best-corrected visual acuity; AL: Axial length; HM, Hand movement; VH: Vitreous haemorrhage; SRH: Subretinal haemorrhage; FTMH: Full-thickness macular hole; SO: Silicon oil; PL: Perception of light; IT-BRAO: Infero-temporal branch retinal artery occlusion; FC: Finger counting; *: vitrectomy avoided in view of advanced proliferative vitreoretinopathy changes and poor visual prognosis; RD: retinal detachment) |
Author |
Type of injection |
RD |
Management |
Outcome |
||
---|---|---|---|---|---|---|
Surgery |
Laser/ Cryopexy |
Anatomical |
Visual |
|||
Grizzard et al (1991)16 |
Retro (5) Peri (4) NA (3) |
5/12 |
5 |
5 |
Attached − 9 (75.0%) Detached − 2 Peripheral detachment − 1 |
≥ 20/40: 7 20/50 − 20/200: 0 19/200-3/200: 1 ≤FC: 4 |
Duker et al (1991)19 |
Retro (18) Peri (2) |
11/20 |
16 |
0 |
Attached − 15 Detached − 5 |
≥ 20/40: 3 20/50 − 20/200: 3 19/200-3/200: 1 ≤FC: 13 |
Hay et al (1991)18 |
Retro (12) Peri (11) |
14/23 |
13 |
5 |
Attached − 19 Detached − 4 |
≥ 20/40: 6 20/50 − 20/200: 3 19/200-3/200: 3 ≤FC: 11 |
Rinkoff et al (1991)10 |
Retro (11) NA (1) |
3/12 |
6 |
5 |
Attached − 10 Detached − 2 |
≥ 20/40: 3 20/50 − 20/200: 6 19/200-3/200: 2 ≤FC: 1 |
McCombe et al (1993)6 |
Retro (9) Peri (2) NA (2) |
4/13 |
9 |
NA |
Attached − 12 Detached − 1 |
≥ 20/40: 6 20/60 − 20/80: 4 ≤FC: 11 |
Wearne et al (1998)17 |
Retro (14) Peri (4) NA (2) |
10/20 |
17 |
1 |
Attached − 11 Detached − 9 |
≥ 20/40: 7 20/50 − 20/200:5 19/200-3/200: 0 ≤FC: 8 |
Gadkari et al (2007)14 |
Retro (6) Peri (10) Subconj (3) |
8/19 |
14 |
4 |
Attached − 18 Detached − 1 |
≥ 20/40: 7 20/50 − 20/200: 7 19/200-3/200: 2 ≤FC: 3 |
(RD: Retinal detachment; Retro: Retroocular; Peri: Peribulbar; NA: Not available; FC: Finger counting; Subconj: Subconjunctival) |
Scleral perforation is a rare but one of the most devastating complications of local ocular anesthesia.1–31 Studies have suggested an incidence of 0.007–0.13%, with the rate being higher for retrobulbar blocks than peribulbar.1,2,6,9,12,14,21 The incidence of globe perforation at our center was similar to that reported in literature. The risk factors for this unfortunate incident include posterior staphyloma, long axial length, uncooperative patient, multiple attempts and inexperienced personnel.4–6, 8,12–15, 18,19 A combination of these factors was responsible for globe perforation in our series.
The early indicators of globe perforation include movement of eyeball while moving the anesthetic needle, unusual difficulty while injecting, severe pain response, sudden increase in the intraocular pressure or severe hypotony, corneal clouding, change in the ocular red reflex, sudden loss of vision, visible enlargement of the eyeball, and popping sound.9–11, 14,21 However, it is not always easy to identify the perforation at the time of injecting. In our case series, only half patients were identified to have perforations. Other authors have also reported that most perforations are recognized in the post-operative period.3,4,7,10,15,17,18
The early management remains controversial. While some authors advocate postponing the planned surgery, others recommend proceeding with the same. In case the cataract is dense, it is better to proceed with the surgery. No contraindication for the placement of an intraocular lens has yet been reported.6,10, 15–17,19 In our case series, all but one patient underwent the surgery immediately without any intra-operative complications. A vitreoretinal opinion should be sought as early as perforation is suspected. In case of a clear media, treatment of the site of perforation leads to a good outcome. None of such patients in our case series progressed to RD. This may be due to a pre-existing posterior vitreous detachment or scar formation subsequent to the local inflammatory reaction produced around the site of the tear.6,9,10,15 It is imperative to mention that these patients need to be followed-up closely as subretinal fluid can accumulate rapidly.
The presence of VH with or without RD warrants an immediate vitrectomy due to aggressive development of PVR changes.4, 6–10,14, 15–17,19,21 One patient in our series, who presented 4 months after the perforation had such advanced PVR that surgery could not be performed. An early surgery in the other patients helped achieve cent percent anatomical success. The retina remained attached even after tamponade was removed. The outcome of patients in our case series were better than reported earlier.6,10,14,16−19 This may be due to early recognition and timely management as well as improvement in the technique of vitreoretinal surgery over the years. Table 4 summarises the results of the previous studies reporting the management outcomes of ocular perforation during local ocular anaesthesia.
More than half the patients achieved BCVA ≥ 20/80. As reported in the literature, the patients with RD in our series also had a worse visual outcome than those without RD.6,18,19 One-fourth patients achieved a final BCVA < 20/200. The causes for poor visual outcome in these cases included vascular occlusion (n = 3), retinal necrosis inside the macula (n = 1), RD with advanced PVR changes (n = 1) and failed PKP graft (n = 1). Retinal vascular occlusions may be caused by inadvertent injection of the medication into the globe leading to a sudden rise of intraocular pressure, popularly called as ocular explosion.11,17 Even in case of scleral perforation, utmost care should be taken to prevent injecting the anaesthetic agent intraocularly as it can lead to mechanical as well as chemical damage. One-fourth patients achieved a final BCVA 20/120 − 20/200. The causes for sub-optimal gain in vision in these patients included macular pathologies like FTMH, SRH and macular pucker. Other authors have also reported poor visual outcome due to macular injury during the anaesthesia.4,9,18,21,28−30
To the best of our knowledge, this is the largest case series till date evaluating the management of inadvertent scleral perforation during peribulbar anesthesia. The limitations of the study include its retrospective nature and small sample size.
In conclusion, it is important to be extremely cautious while giving peribulbar anesthesia in high-risk cases or shift to safer techniques like subtenon anesthesia. Ocular perforation should be suspected when fresh VH is noted on the first POD. Early appropriate intervention for associated complications can help achieve a good outcome to the patients with inadvertent perforation. Risk factors for poor outcome include intraocular injection of the anesthetic drugs, macular injury and RD.
Compliance with Ethical Standards:
Funding: This study was not funded by anyone
Conflict of Interest: All authors certify that they have no conflict of interests.
(Humans were involved in study) Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
(Humans were involved in study) Informed consent: Informed consent was obtained from all individual participants included in the study.
(Animals were not involved) Ethical approval: This article does not contain any studies with animals performed by any of the authors.
31. Dubey D, Shanmugam M, Ramanjulu R, Mishra KCD, Doshi B (2019). Swept source optical coherence tomography in globe perforation. Indian J Ophthalmol. ; 67(10): 1697-8.